Tag: Haseeb Ahmad

Novartis gets Pluvicto EC approval for advanced prostate cancer

Raghuram Kadari- December 15, 2022

Novartis has received the approval of the European Commission (EC) for Pluvicto (lutetium (177Lu) vipivotide tetraxetan), a targeted radioligand therapy for advanced prostate cancer. Following ... Read More